Twenty-five years of HIV: Lessons for low prevalence scenarios

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue SUPPL. 3, 2009, Pages

  Sawires, Sharif ^a,e   Birnbaum, Nina ^b   Abu Raddad, Laith ^c   Szekeres, Greg ^a   Gayle, Jacob ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d FORD FOUNDATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gender; HIV; HIV policy; HIV programs; HIV structural approaches; Low prevalence

Indexed keywords

ACICLOVIR;

CIRCUMCISION; CONDOM; CULTURAL FACTOR; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG USE; EPIDEMIC; GOVERNMENT; HERPES SIMPLEX; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE HOMOSEXUAL; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SEXUALLY TRANSMITTED DISEASE;

AFRICA, NORTHERN; DISEASE OUTBREAKS; FEMALE; GENDER IDENTITY; HIV INFECTIONS; HUMANS; MALE; MIDDLE EAST; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SOCIOLOGY;

EID: 67749147186     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181aafd01     Document Type: Review

References (81)

1. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR Morb Mortal Wkly Rep. 1981;30:305-308.
2. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868-871.
3. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372:669-684.
4. Cohen J. HIV/AIDS. Prevention cocktails: combining tools to stop HIV's spread. Science. 2005;309:1002-1005.
5. Piot P, Bartos M, Larson H, et al. Coming to terms with complexity: a call to action for HIV prevention. Lancet. 2008;372:845-859.
6. Bernays S, Rhodes T, Barnett T. Hope: a new way to look at the HIV epidemic. AIDS. 2007;21(Suppl 5):S5-S11.
7. Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57:13-24.
8. IOM (Institute of Medicine). 2008. Methodological challenges in biomedical HIV prevention trials. Washington, DC: The National Academies Press. p. 2.
9. Farmer PE, Nizeye B, Stulac S, et al. Structural violence and clinical medicine. PLoS Med. 2006;3(10):e449.
10. Harvey SM, Bird ST, Galavotti C, et al. Relationship power, sexual decision making and condom use among women at risk for HIV/STDS. Women Health. 2002;36:69-84.
11. Harvey SM, Bird ST. What makes women feel powerful? An exploratory study of relationship power and sexual decision-making with African Americans at risk for HIV/STDs. Women Health. 2004;39:1-18.
12. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. AIDS. 2002;16:135-149.
13. Prata N, Morris L, Mazive E, et al. Relationship between HIV risk perception and condom use: evidence from a population-based survey in Mozambique. Int Fam Plan Perspect. 2006;32:192-200.
14. Goldstein N, Manlowe JL. The Gender Politics of HIV/AIDS in Women: Perspectives on the Pandemic in the United States. New York, NY: New York University Press; 1997.
15. Amaro H, Raj A. On the margin: power and women's HIV risk reduction strategies. Sex Roles. 2000;42:723-749.
16. Quina K, Harlow L, Morokoff P, et al. Sexual communication in relationships: when words speak louder than actions. Sex Roles. 2000;42:523-549.
17. Wyatt. Factors affecting HIV contraceptive decision-making among women. Sex Roles. 2000;42:495-521.
18. Simon J, Walter K, Nero D. Safer sex among HIV+ women: the role of relationships. Sex Roles. 2000;42:691-708.
19. Norman A, Chopra M, Kadiyala S. Factors related to HIV disclosure in 2 South African communities. Am J Public Health. 2007;97:1775-1781.
20. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370:251-261.
21. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 1992;268(4):477-482.
22. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360:971-977.
23. Halpern V, et al. Effectiveness of cellulose sulfate gel for prevention of HIV: results of the phase III trial in Nigeria. Presented at: The 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 2007. Abstract WESS302.
24. Halpern V, Ogunsola F, Obunge O, et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a phase III trial in Nigeria. PLoS ONE. 2008;3:e3784
25. Van Damme L, Govinden R, Mirembe FM, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359:463-472.
26. Krishnan S, Dunbar MS, Minnis AM, et al. Poverty, gender inequities, and women's risk of human immunodeficiency virus/AIDS. Ann N Y Acad Sci. 2008;1136:101-110.
27. Hardy E, Hebling EM, Sousa MH, et al. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences. Contraception. 2007;76:126-131.
28. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298.
29. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643-656.
30. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657-666.
31. Drain PK, Halperin DT, Hughes JP, et al. Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis. 2006;6:172.
32. Gruskin S. Male circumcision, in so many words. Reprod Health Matters. 2007;15(29):49-52.
33. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001;28:579-597.
34. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(Suppl 3):5-7.
35. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73-83.
36. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008;358:1560-1571.
37. Celum C,Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:2109-2119.
38. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2007. Atlanta, GA: US Department of Health and Human Services; December 2008. Available at http://www.cdc.gov/std/stats07/toc.htm. Accessed May 20, 2009.
39. World Health Organization, UNAIDS, UNICEF. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector: Progress Report, April 2007. Geneva, Switzerland: World Health Organization; 2007.
40. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17; quiz CE1-4.
41. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-453.
42. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-1450.
43. Denison JA, O'Reilly KR, Schmid GP, et al. HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990-2005. AIDS Behav. 2008;12:363-373.
44. Obermeyer CM, Osborn M. The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Health. 2007;97:1762-1774.
45. Mahajan AP, Sayles JN, Patel VA, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22(Suppl 2):S67-S79.
46. Sayles JN, Hays RD, Sarkisian CA, et al. Development and psychometric assessment of a multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults. AIDS Behav. 2008;12:748-758.
47. Gruskin S. The more things change. In: Mann J, ed. Health and Human Rights: A Reader. New York, NY: Routledge; 1999: 505.
48. Gruskin S. Perspectives on Health and Human Rights. New York, NY: Routledge; 2005.
49. Hunt P. Hunt P. Report of the Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health. 2007 [cited 2009 January 17]; Available from: http://daccessdds.un.org/doc/UNDOC/GEN/G08/105/03/PDF/G0810503.pdf?OpenElement. Accessed May 20, 2009.
50. Barnett T. A long-wave event. HIV/AIDS, politics, governance and 'security': sundering the intergenerational bond? Int Aff. 2006;82:931-952.
51. Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14(Suppl 1):S11-S21.
52. Blankenship KM, Friedman SR, Dworkin S, et al. Structural interventions: concepts, challenges and opportunities for research. J Urban Health. 2006;83:59-72.
53. Lane SD, Keefe RH, Rubinstein R, et al. Structural violence, urban retail food markets, and low birth weight. Health Place. 2008;14:415-423.
54. Lane SD, Rubinstein RA, Keefe RH, et al. Structural violence and racial disparity in HIV transmission. J Health Care Poor Underserved. 2004;15:319-335.
55. Rhodes T, Singer M, Bourgois P, et al. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61:1026-1044.
56. Greig A, Kimmel M, Lang J. Men, Masculinities and Development: Broadening Our Work Towards Gender Equality. Geneva, Switzerland: UNDP; 2000.
57. Roithmayr D. Locked in segregation. Virginia Journal of Social Policy and the Law. 2004;12.
58. Grown C, Gupta GR, Pande R. Taking action to improve women's health through gender equality and women's empowerment. Lancet. 2005;365:541-543.
59. World Bank. The status and progress of women in the Middle East and North Africa. 2009. Available at: http://go.worldbank.org/JHKHW3REV0. Accessed April 1, 2009.
60. Kim J, Pronyk P, Barnett T, et al. Exploring the role of economic empowerment in HIV prevention. AIDS. 2008;22(Suppl 4):S57-S71.
61. Anderson R. The spread of HIVand sexual mixing patterns. In: Mann JM, Tarantola DJM, eds. AIDS in the World II: Global Dimensions, Social Roots, and Responses. New York, NY: Oxford University Press; 1996:71-86.
62. Cohen J, Amon J. Governance, human rights and infectious disease: theoretical, empirical and practical perspectives. In: Mayer KH, Pizer HF, eds. Social Ecology of Infectious Diseases. New York, NY: Academic Press; 2007.
63. Low-Beer D. HIV-1 incidence and prevalence trends in Uganda. Lancet. 2002;360:1788; Author reply 1788-1789.
64. Stoneburner RL, Low-Beer D. Sexual partner reductions explain human immunodeficiency virus declines in Uganda: comparative analyses of HIV and behavioural data in Uganda, Kenya, Malawi, and Zambia. Int J Epidemiol. 2004;33:624.
65. Stoneburner RL, Low-Beer D. Population-level HIV declines and behavioral risk avoidance in Uganda. Science. 2004;304:714-718.
66. UNAIDS. A Tale of Three Countries - An Update on HIV Prevention Success in Senegal, Thailand, and Uganda. Geneva, Switzerland; 2001. Available at: http://data.unaids.org/Publications/IRC-pub02/jc535-hi-en.pdf. Accessed March 1, 2009.
67. Ungphakorn J, Sittitrai W. The Thai response to the HIV/AIDS epidemic. AIDS. 1994;8(Suppl 2):S155-S163.
68. Punpanich W, Ungchusak K, Detels R. Thailand's response to the HIV epidemic: yesterday, today, and tomorrow. AIDS Educ Prev. 2004;16(3 Suppl A):119-136.
69. Louisirirotchanakul S,Wasi C, Uneklabh C, et al. High prevalence of delta virus infection in Thai intravenous drug abusers. Southeast Asian J Trop Med Public Health. 1988;19:191-195.
70. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS. 1991;5(Suppl 2):S71-S85.
71. Thai Working Group on HIV/AIDS Projection. Projections for HIV/AIDS in Thailand: 2000-2020. Bangkok, Thailand: AIDS Division, Department of Communicable Disease Control, Ministry of Public Health, Thailand; 2001.
72. Beyrer C, Gauri V, Vaillancourt D. Evaluation of the World Bank's Assistance in Responding to the AIDS Epidemic: Brazil Case Study. Washington, DC: The World Bank; 2005.
73. Candiani TM, Pinto J, Cardoso CA, et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil. Cad Saude Publica. 2007;23(Suppl 3):S414-S423.
74. Silva MT, Araujo A. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil. J Neurovirol. 2005;11(Suppl 3):11-15.
75. Okie S. Fighting HIV - lessons from Brazil. N Engl J Med. 2006;354:1977-1981.
76. Nunn AS, Fonseca EM, Bastos FI, et al. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Med. 2007;4(11):e305.
77. Kippax S, Race K. Sustaining safe practice: twenty years on. Soc Sci Med. 2003;57:1-12.
78. Yoon C. AsiaSource interview with Dr. Chris Beyrer. 2002. Available at: http://www.asiasource.org/news/special-reports/beyrerinterview.cfm. Accessed May 15, 2008.
79. Epstein H. The Invisible Cure: Africa, the West, and the Fight Against AIDS. 1st ed. New York, NY: Farrar, Straus, and Giroux; 2007.
80. Bonell C, Imrie J. Behavioural interventions to prevent HIV infection: rapid evolution, increasing rigour, moderate success. Br Med Bull. 2001;58:155-170.
81. Jaffe HW, Valdiserri RO, De Cock KM. The reemerging HIV/AIDS epidemic in men who have sex with men. JAMA. 2007;298:2412-2414.